title: Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.
abstract: It has been demonstrated that MDM2 is a well-established negative regulator of the p53 protein and might be associated with a significantly earlier age of onset of several tumors, including colorectal cancer (CRC). In recent years, a T to G substitution (SNP309) in the promoter of MDM2 has been extensively studied as a potential CRC risk factor; however, the results are inconsistent. To derive a more precise estimation of association between MDM2 SNP309 polymorphism and CRC risk, we conducted a meta-analysis of 11 studies with 4,050 CRC cases and 3,688 controls. For MDM2 SNP309 polymorphism, no obvious associations were found for all genetic models when all studies were pooled into the meta-analysis. In the subgroup analyses by ethnicity, source of controls, and Hardy-Weinberg equilibrium (HWE) in controls, a significantly increased risk was observed among Asians (heterozygous model: odds ratio (OR) = 1.21, 95% confidence interval (CI) = 1.06-1.39, P = 0.005), population-based studies (heterozygous model: OR = 1.17, 95% CI = 1.02-1.34, P = 0.027), and among studies without the HWE (recessive model: OR = 1.42, 95% CI = 1.03-1.94, P = 0.030). When excluding three studies deviated from HWE, the significant results were also observed for heterozygous model in overall population (OR = 1.16, 95% CI = 1.02-1.31, P = 0.020). No publication bias was found in the present study. In conclusion, this meta-analysis suggests that MDM2 SNP309 polymorphism was associated with CRC susceptibility, especially among Asians. Further research is needed to assess possible gene-gene or gene-environment-lifestyle interactions on CRC.
authors.affiliation: General Surgery Department, Tumor Hospital Affiliated Hospital of Zhengzhou University Henan Tumor Hospital, Zhengzhou, Henan, 450000, China.
authors.forename: Qiang
authors.initials: Q
authors.lastname: Fu
authors.forename: Guoqiang
authors.initials: G
authors.lastname: Zhang
authors.forename: Hongwei
authors.initials: H
authors.lastname: Chen
authors.forename: Youwei
authors.initials: Y
authors.lastname: Zheng
authors.forename: Jing
authors.initials: J
authors.lastname: Cheng
mesh_terms: D044466:Asian People / Q000235:genetics; D015179:Colorectal Neoplasms / Q000208:ethnology / Q000235:genetics*; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease / Q000208:ethnology / Q000235:genetics*; D005838:Genotype; D006801:Humans; D015810:Linkage Disequilibrium; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D051736:Proto-Oncogene Proteins c-mdm2 / Q000235:genetics*; D012307:Risk Factors; D044465:White People / Q000235:genetics
chemical_list: C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2
references.citation: Oncogene. 2007 Feb 26;26(9):1317-23
references.pmid: 17322917
references.citation: BMJ. 1997 Sep 13;315(7109):629-34
references.pmid: 9310563
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15608-12
references.pmid: 9861017
references.citation: Mol Pathol. 1998 Feb;51(1):26-9
references.pmid: 9624416
references.citation: EMBO J. 1991 Jun;10(6):1565-9
references.pmid: 2026149
references.citation: J Natl Cancer Inst. 2006 Feb 15;98(4):285-8
references.pmid: 16478747
references.citation: J Natl Cancer Inst. 1959 Apr;22(4):719-48
references.pmid: 13655060
references.citation: Control Clin Trials. 1986 Sep;7(3):177-88
references.pmid: 3802833
references.citation: Mol Biol Rep. 2012 Oct;39(10):9661-8
references.pmid: 22744426
references.citation: Stat Med. 2002 Jun 15;21(11):1539-58
references.pmid: 12111919
references.citation: Jpn J Clin Oncol. 2010 Apr;40(4):281-5
references.pmid: 20085904
references.citation: Am J Epidemiol. 2002 Aug 15;156(4):300-10
references.pmid: 12181099
references.citation: Eur J Cancer. 2010 Mar;46(4):765-81
references.pmid: 20116997
references.citation: Genes Chromosomes Cancer. 2010 Jul;49(7):620-9
references.pmid: 20461754
references.citation: Mol Med. 1999 Feb;5(2):71-83
references.pmid: 10203572
references.citation: Jpn J Clin Oncol. 2011 Feb;41(2):232-8
references.pmid: 21051533
references.citation: Cancer Res. 2005 Jul 1;65(13):5481-4
references.pmid: 15994915
references.citation: Cell. 2004 Nov 24;119(5):591-602
references.pmid: 15550242
references.citation: Int J Cancer. 2007 Feb 1;120(3):563-5
references.pmid: 17096342
references.citation: Am J Epidemiol. 2006 Feb 15;163(4):300-9
references.pmid: 16410351
references.citation: Am J Epidemiol. 2010 Nov 1;172(9):1000-14
references.pmid: 20937634
references.citation: J Med Genet. 2007 Jan;44(1):75-80
references.pmid: 16825434
references.citation: Eur J Hum Genet. 2004 May;12(5):395-9
references.pmid: 14872201
references.citation: Eur J Gastroenterol Hepatol. 2012 Mar;24(3):320-7
references.pmid: 22266832
references.citation: Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):335-8
references.pmid: 18953830
references.citation: Hum Genet. 2003 Apr;112(4):434-5
references.pmid: 12574941
references.citation: Nucleic Acids Res. 1998 Aug 1;26(15):3453-9
references.pmid: 9671804
references.citation: Cell. 2000 Oct 13;103(2):321-30
references.pmid: 11057904
references.citation: Cancer Biol Ther. 2008 Dec;7(12):1959-67
references.pmid: 18981727
references.citation: N Engl J Med. 2000 Jul 13;343(2):78-85
references.pmid: 10891514
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16297-302
references.pmid: 16260726
references.citation: Nucleic Acids Res. 1995 Jul 25;23(14):2584-92
references.pmid: 7651818
references.citation: J Med Genet. 2006 Dec;43(12):950-2
references.pmid: 16825430
references.citation: Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6840-4
references.pmid: 16203772
references.citation: Dis Colon Rectum. 2008 Sep;51(9):1395-402
references.pmid: 18607552
references.citation: Apoptosis. 2011 Jan;16(1):35-44
references.pmid: 20812030
references.citation: J Med Genet. 2005 Sep;42(9):694-8
references.pmid: 16141004
references.citation: Cell Mol Life Sci. 1999 Jan;55(1):96-107
references.pmid: 10065155
references.citation: Br J Cancer. 2004 Oct 18;91(8):1415-9
references.pmid: 15452548
references.citation: Eur J Hum Genet. 2005 Jul;13(7):840-8
references.pmid: 15827565
references.citation: DNA Cell Biol. 2012 Mar;31(3):355-9
references.pmid: 21770737
references.citation: Lancet Oncol. 2005 Nov;6(11):871-6
references.pmid: 16257795
references.citation: Am J Hum Genet. 2003 Mar;72(3):598-610
references.pmid: 12587097
references.citation: Anal Bioanal Chem. 2009 Jul;394(5):1291-7
references.pmid: 19015838